This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Read More

Bronchiectasis Therapeutic Market

Bronchiectasis Therapeutic Market

Bronchiectasis Therapeutic Market

Bronchiectasis Therapeutic Market: Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

Bronchiectasis Therapeutic Market Overview

COVID-19 IMPACT ON THE BRONCHIECTASIS THERAPEUTIC MARKET

Bronchiectasis is a lung condition that causes coughing up mucus due to scarred tissue in the bronchi, or the passages that let air in the lungs. The condition is fairly common among people aged 75 and older, but it can also happen to young people.

The global bronchiectasis therapeutic market can be segmented based on product type as antibiotics, expectorants and other drugs. The antibiotics segment is expected to lead the growth of the bronchiectasis therapeutic market as a result of increasing prevalence of respiratory disorders worldwide.

With the COVID-19 breakout in December 2019, the disease has affected more than 200 countries. Therefore, it is important to take this into consideration while addressing antibody bronchiectasis market.

The disease may have led to temporary lag in the bronchiectasis therapeutic market, but in the long run the bronchiectasis therapeutic market is expected to pace up and flourish at a significant rate during the forecast period 2020-2030.

Additionally, the research studies on COVID-19 suggests, that it affects functioning of the lungs. This may lead to further growth of the respiratory diseases worldwide and widening the growth prospects for bronchiectasis therapeutic market.

Bronchiectasis Therapeutic Market : Drivers and Restraints

The increasing prevalence of respiratory diseases is expected to boost the growth of the global brochiectasis therapeutic market. The availability of low cost drugs off-label generics in developed and underdeveloped countries is the major factor driving the growth of the brochiectasis therapeutic market.

However, lack of approved drugs for bronchiectasis and stringent regulatory policies are expected to restrict the growth of the global bronchiectasis therapeutic market. Additionally, the high cost involved in the research and development under diagnosis of bronchiectasis and preference for substitute treatment options are factors that may also hamper the growth of the bronchiectasis therapeutic market.

Bronchiectasis Therapeutic Market : Overview

The global market for bronchiectasis therapeutic market is estimated to experience a significant growth due to the increasing demand for the treatment of bronchiectasis. Based on type, the global bronchiectasis therapeutic market is segmented into antibiotics, expectorants and others. The antibiotics segment is expected to account for the highest market share in the forecast years due to the growing prevalence of several respiratory disorders.

Based on distribution channels, the bronchiectasis therapeutic market may be divided into hospital pharmacies, retail pharmacies and online pharmacies. Hospital pharmacies and retail pharmacies are expected to contribute the largest portion of revenue in the forecast years.

However, with the rapid changes in technology and growing acceptance of e-commerce by the people worldwide may lead to the growth of the online pharmacies in the forecast years.

Bronchiectasis Therapeutic Market: Regional-Wise Outlook

Geographically, the bronchiectasis therapeutic market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa.

The North America is expected to dominate the global bronchiectasis therapeutic market due to rising prevalence of bronchoectasis, increasing research and development activities for the drug development and technology advancements for the treatment of bronchiectasis.

Europe is expected to have the second largest share in the bronchiectasis therapeutic market due to increasing prevalence of bronchiectasis therapeutic market. East Asia is expected to observe a substantial growth in the bronchiectasis therapeutic market due to availability of funds for research and development.

On the other hand, South Asia is anticipated to experience fastest growth in the bronchiectasis therapeutic market as a result of rising incidence of respiratory diseases. In the Middle East and Africa the market growth is expected to be limited due to slow economic growth, underdeveloped infrastructure and lower access to technological advancement.

Bronchiectasis Therapeutic Market : Key players

Some of the players identified in the bronchiectasis therapeutic market include:

  • GlaxoSmithKline
  • Alitair Pharmaceuticals Inc.
  • Bayer AG
  • Chiesi Farmaceutici SpA
  • Grifols SA
  • Insmed Inc
  • Kamada Ltd
  • Polyphor Ltd
  • Recipharm AB

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the bronchiectasis therapeutic market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa

bronchiectasis therapeutic market Report Highlights:

  • Overview of Global Healthcare Market
  • Evolution of the technology
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Bronchiectasis Therapeutic Market: Segmentation

Tentatively, the global bronchiectasis therapeutic market has been segmented on the basis of product type and distribution channel.

By Product type:

  • Antibiotics
  • Expectorants
  • Others

By distribution channel:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

Need specific information?

Our Clients

Healthcare

View All Reports from Healthcare

View Reports

Recommendations

Healthcare

Therapeutic Nuclear Medicines Market

Published : 2019-01-14

Healthcare

Pneumonia Diagnostic Market

Published : 2017-11-07

Healthcare

Biopharmaceutical Contract Manufacturing Market

Published : 2020-01-23